BOSTON--(BUSINESS WIRE)-- <\/p>\n
Joslin Diabetes Center, an affiliate of Harvard Medical School, has joined forces with Humedica to redefine traditional models of continuing medical education (CME) by leveraging Humedicas de-identified clinical data assets and offering providers an opportunity to participate in education or research activities designed to improve care based on identified gaps. <\/p>\n
The collaboration is kicking off with a series of innovative projects, each starting with a baseline analysis of retrospective real-world practice patterns of patients with type 2 diabetes. Each analysis includes both process measures and patient outcomes data. Initial topics include: <\/p>\n
I. Comparison of data methods for assessing physicians practice patterns <\/p>\n
II. Improving clinician proficiency in insulin initiation and management <\/p>\n
III. Examining barriers to optimal care of patients with post-prandial glycemia <\/p>\n
John Brooks, President and Chief Executive Officer of Joslin says, \"Big data provides a new frontier to drive health care quality improvements, and Humedica is well positioned to support Joslin in our ongoing efforts to positively impact diabetes care through data analytics and clinical support driven initiatives. <\/p>\n
Michael Weintraub, Humedicas President and CEO, adds, Working with Joslin is a natural fit for us. Supporting research that examines and improves the way healthcare is delivered is an extension of the value we create for our providers today - transforming clinical data into actionable insights and meaningful results. <\/p>\n
Humedica will be providing Joslins researchers access to a de-identified clinically robust, population health data set, and coordinating with their partner, the American Medical Group Association (AMGA) to engage providers to participate in performance focused CME or other research initiatives. Current projects are supported via independent educational grants from Sanofi, Pfizer, GlaxoSmithKline and Lilly. <\/p>\n
This is the new direction for continuous quality improvement, adds Julie Brown, CCMEP, director of professional education at Joslin. Through the combination of Humedicas clinical data and provider network, and Joslins performance focused CME program, we are able for the first time to efficiently leverage actual clinical performance and outcomes so we can better understand physicians unmet needs in diabetes and cardiometabolic health. Only then can we prospectively address these gaps through targeted interventions. This data-education combination will position continuing medical education where it belongs - at the center of medical practice where it can be used as a tool to enhance quality and value. <\/p>\n
<\/p>\n
Original post: <\/p>\n
Joslin Diabetes Center and Humedica Launch Strategic Collaboration to Improve Quality and Efficiency of Care and ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" BOSTON--(BUSINESS WIRE)-- Joslin Diabetes Center, an affiliate of Harvard Medical School, has joined forces with Humedica to redefine traditional models of continuing medical education (CME) by leveraging Humedicas de-identified clinical data assets and offering providers an opportunity to participate in education or research activities designed to improve care based on identified gaps. Continue reading